相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use
Jing Sun et al.
SCIENCE SIGNALING (2016)
Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use
Jing Sun et al.
SCIENCE SIGNALING (2016)
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
William T. McElroy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4
W. Michael Seganish et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4
Zhulun Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome
Glynis Frans et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
Priscilla N. Kelly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
A historical overview of protein kinases and their targeted small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
William T. McElroy et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors
W. Michael Seganish et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
Divya Chaudhary et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
L. Nathan Tumey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Yu Liu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner
Leah Cushing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Kinase Drug Discovery - What's Next in the Field?
Philip Cohen et al.
ACS CHEMICAL BIOLOGY (2013)
Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice
Eduardo Pauls et al.
JOURNAL OF IMMUNOLOGY (2013)
The problem of choice: current biologic agents and future prospects in RA
Ernest H. Choy et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells
Margherita Coccia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immune Complex-Mediated Cell Activation from Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients Elaborate Different Requirements for IRAK1/4 Kinase Activity across Human Cell Types
Eugene Y. Chiang et al.
JOURNAL OF IMMUNOLOGY (2011)
Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
Yijun Carrier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Interleukin-1β and Interleukin-6 in Arthritis Animal Models: Roles in the Early Phase of Transition from Acute to Chronic Inflammation and Relevance for Human Rheumatoid Arthritis
Gianfranco Ferraccioli et al.
MOLECULAR MEDICINE (2010)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard et al.
MEDICINE (2010)
Interleukin-1 Receptor-Associated Kinase 4 Links Innate Immunity to the Pathogenesis of Rheumatoid Arthritis
Leo A. B. Joosten et al.
ARTHRITIS AND RHEUMATISM (2009)
The Critical Role of Kinase Activity of Interleukin-1 Receptor-Associated Kinase 4 in Animal Models of Joint Inflammation
Magdalena Koziczak-Holbro et al.
ARTHRITIS AND RHEUMATISM (2009)
IRAK-4 Inhibitors for Inflammation
Zhulun Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Signalling mechanisms for Toll-like receptor-activated neutrophil exocytosis: key roles for interleukin-1-receptor-associated kinase-4 and phosphatidylinositol 3-kinase but not Toll/IL-1 receptor (TIR) domain-containing adaptor inducing IFN-β (TRIF)
Agnieszka A. Brzezinska et al.
IMMUNOLOGY (2009)
IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated Disease
Kirk A. Staschke et al.
JOURNAL OF IMMUNOLOGY (2009)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Leslie van der Fits et al.
JOURNAL OF IMMUNOLOGY (2009)
The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells
Kyung W. Song et al.
MOLECULAR IMMUNOLOGY (2009)
IRAK4 in TLR/IL-1R signaling: Possible clinical applications
Xiaoxia Li
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress
Luke A. J. O'Neill
IMMUNOLOGICAL REVIEWS (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Pyogenic bacterial infections in humans with MyD88 deficiency
Horst von Bernuth et al.
SCIENCE (2008)
Crystal structures of IRAK-4 kinase in complex with inhibitors: A serine/threonine kinase with tyrosine as a gatekeeper
Zhulun Wang et al.
STRUCTURE (2006)
IRAK-4 -: a shared NF-κB activator in innate and acquired immunity
Nobutaka Suzuki et al.
TRENDS IN IMMUNOLOGY (2006)
Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4
JP Powers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background
F Zhou et al.
ARTHRITIS AND RHEUMATISM (2005)
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction
S Uematsu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Pyogenic bacterial infections in humans with IRAK-4 deficiency
C Picard et al.
SCIENCE (2003)
IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
SY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
分享论文
